Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1996 (LINC01996)
- Target
- LINC01996
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Non-coding RNA
01
Overview
Long intergenic non-protein coding RNA 1996 (LINC01996) is a human long intergenic non-coding RNA (lincRNA) gene that does not encode a protein and does not overlap any protein-coding gene[1][3][7]. LincRNAs are a subclass of long non-coding RNAs (lncRNAs), defined as autonomously transcribed RNA molecules longer than 200 nucleotides, and are typically involved in regulating gene expression, chromatin architecture, RNA stability, and other nuclear processes without being translated into proteins[3][7]. Most lincRNAs, including LINC01996, are not fully characterized, and their specific biological functions or disease associations remain largely unknown[1][3][5][7]. There is no current evidence or consensus that LINC01996 is a validated therapeutic target, nor are there known drugs, biomarkers, or safety concerns related to this lincRNA[1].
- Other names
- LINC01996
02
Biological functions
Gene expression regulationChromatin remodelingRNA stabilizationTranscription regulationEnhancer-associated activity (general for lincRNAs) [3][7]
03
Disease associations
Other (no clear, specific disease involvement established for LINC01996 in the provided results; possible general lincRNA roles in cancer and gene regulation) [3][5][7]
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1996 (LINC01996).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1996 (LINC01996).